Alcohol and Tobacco Consumption in Patients With Head and Neck Cancer : Interest of an Addiction Support

NCT ID: NCT01652456

Last Updated: 2018-01-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2012-10-31

Study Completion Date

2017-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a multicenter, interventional, randomized study for preventive and therapeutic strategies for patients with head and neck or Lung cancer; contribution of an addiction support

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Head and Neck Cancer Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

Group Type EXPERIMENTAL

Addiction support

Intervention Type OTHER

one consultation with an addiction specialist

Group B

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Addiction support

one consultation with an addiction specialist

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* first head and neck or lung cancer
* first support
* 18 ≤ age ≤ 60
* lives in Lille Metropolis
* having an addiction to alcohol and tobacco
* covered by health insurance
* signed informed consent

Exclusion Criteria

* prior cancer
* mesothelioma and oesophageal cancer
* unable to undergo trail medical follow up (geographical, social and psychological reasons)
* pregnant or nursing woman
* patient under guardianship
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Oscar Lambret

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Corinne VANNIMENUS, MD

Role: STUDY_DIRECTOR

Centre Hospitalier Régional et Universitaire

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Oscar Lambret Center

Lille, , France

Site Status

Centre Hospitalier Régional et Universitaire - Hopital CALMETTE

Lille, , France

Site Status

Centre Hospitalier Régional et Universitaire - Hopital HURIEZ

Lille, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ALTAKRA - 1205

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Smoking Cessation Treatment for Head & Neck Cancer Patients
NCT01098955 ACTIVE_NOT_RECRUITING EARLY_PHASE1
Tobacco Use Treatment in Cancer Patients
NCT03482583 COMPLETED PHASE4